Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Disease | 196 | 2024 | 6485 | 14.120 |
Why?
|
Coronary Angiography | 149 | 2023 | 4576 | 13.230 |
Why?
|
Sarcoidosis | 28 | 2024 | 506 | 8.320 |
Why?
|
Myocardial Perfusion Imaging | 48 | 2024 | 555 | 7.000 |
Why?
|
Cardiomyopathies | 39 | 2024 | 1911 | 6.300 |
Why?
|
Tomography, X-Ray Computed | 122 | 2023 | 20121 | 5.830 |
Why?
|
Myocardial Infarction | 60 | 2023 | 11708 | 5.640 |
Why?
|
Coronary Stenosis | 26 | 2023 | 833 | 5.570 |
Why?
|
Chest Pain | 31 | 2023 | 1114 | 5.390 |
Why?
|
Cardiology | 28 | 2023 | 1668 | 4.950 |
Why?
|
Atherosclerosis | 51 | 2024 | 3445 | 4.320 |
Why?
|
Predictive Value of Tests | 146 | 2024 | 15067 | 4.220 |
Why?
|
Coronary Vessels | 52 | 2023 | 3106 | 4.110 |
Why?
|
Fractional Flow Reserve, Myocardial | 21 | 2023 | 289 | 3.910 |
Why?
|
Plaque, Atherosclerotic | 26 | 2023 | 1518 | 3.830 |
Why?
|
Exercise Test | 25 | 2021 | 2074 | 3.680 |
Why?
|
Calcinosis | 25 | 2023 | 1495 | 3.570 |
Why?
|
Cardiovascular Diseases | 71 | 2024 | 15142 | 3.440 |
Why?
|
Cardiac Imaging Techniques | 16 | 2024 | 269 | 3.430 |
Why?
|
Fluorodeoxyglucose F18 | 22 | 2022 | 2016 | 3.330 |
Why?
|
Positron-Emission Tomography | 60 | 2024 | 6237 | 3.280 |
Why?
|
Calcium | 46 | 2024 | 5755 | 3.130 |
Why?
|
Myocarditis | 14 | 2024 | 768 | 3.080 |
Why?
|
Coronary Circulation | 31 | 2023 | 1572 | 2.600 |
Why?
|
Myocardial Ischemia | 24 | 2023 | 2150 | 2.560 |
Why?
|
Registries | 30 | 2023 | 8090 | 2.140 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 26 | 2024 | 1108 | 2.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 23 | 2022 | 3255 | 2.060 |
Why?
|
Heart Diseases | 17 | 2023 | 2789 | 1.990 |
Why?
|
American Heart Association | 14 | 2023 | 1057 | 1.980 |
Why?
|
Magnetic Resonance Imaging, Cine | 20 | 2022 | 962 | 1.980 |
Why?
|
Heart | 22 | 2023 | 4460 | 1.930 |
Why?
|
Humans | 516 | 2024 | 743811 | 1.930 |
Why?
|
Coronary Disease | 22 | 2023 | 6078 | 1.860 |
Why?
|
Risk Assessment | 92 | 2024 | 23327 | 1.760 |
Why?
|
Ventricular Function, Left | 27 | 2023 | 3660 | 1.630 |
Why?
|
Risk Factors | 148 | 2024 | 72252 | 1.590 |
Why?
|
Lipoprotein(a) | 5 | 2024 | 435 | 1.550 |
Why?
|
Aortic Valve Stenosis | 8 | 2023 | 1955 | 1.450 |
Why?
|
Prognosis | 82 | 2024 | 29052 | 1.430 |
Why?
|
Myocardium | 16 | 2023 | 4775 | 1.380 |
Why?
|
Middle Aged | 231 | 2024 | 213241 | 1.340 |
Why?
|
Diagnostic Imaging | 12 | 2023 | 3503 | 1.320 |
Why?
|
Mitral Valve | 8 | 2021 | 1491 | 1.300 |
Why?
|
Hypolipidemic Agents | 5 | 2020 | 606 | 1.290 |
Why?
|
Radiology | 5 | 2022 | 2099 | 1.280 |
Why?
|
Dyslipidemias | 9 | 2019 | 851 | 1.270 |
Why?
|
Coronary Vessel Anomalies | 3 | 2017 | 314 | 1.250 |
Why?
|
Male | 264 | 2024 | 349776 | 1.240 |
Why?
|
Cardiovascular System | 3 | 2020 | 828 | 1.240 |
Why?
|
Cholesterol, LDL | 10 | 2023 | 2354 | 1.230 |
Why?
|
Female | 264 | 2024 | 380020 | 1.180 |
Why?
|
Endocarditis | 4 | 2020 | 349 | 1.180 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2021 | 272 | 1.170 |
Why?
|
Radiation Dosage | 12 | 2019 | 1928 | 1.150 |
Why?
|
Echocardiography | 16 | 2023 | 5096 | 1.140 |
Why?
|
Aortic Valve | 8 | 2023 | 1920 | 1.140 |
Why?
|
Heart Failure | 24 | 2023 | 10896 | 1.130 |
Why?
|
Electrocardiography | 28 | 2020 | 6441 | 1.090 |
Why?
|
Radiopharmaceuticals | 15 | 2022 | 2647 | 1.060 |
Why?
|
Hyperlipoproteinemia Type II | 3 | 2019 | 375 | 1.060 |
Why?
|
Stroke Volume | 26 | 2023 | 5002 | 1.050 |
Why?
|
Heart Atria | 10 | 2021 | 1357 | 1.040 |
Why?
|
Heart Valve Prosthesis | 6 | 2021 | 1489 | 1.010 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2019 | 339 | 0.980 |
Why?
|
Marijuana Abuse | 2 | 2018 | 403 | 0.960 |
Why?
|
Constriction, Pathologic | 12 | 2023 | 1108 | 0.920 |
Why?
|
Diabetic Angiopathies | 3 | 2019 | 819 | 0.910 |
Why?
|
Heart Ventricles | 15 | 2023 | 3817 | 0.890 |
Why?
|
Aged | 164 | 2023 | 163178 | 0.880 |
Why?
|
Severity of Illness Index | 35 | 2020 | 15526 | 0.840 |
Why?
|
Troponin | 5 | 2023 | 524 | 0.840 |
Why?
|
Contrast Media | 22 | 2023 | 5301 | 0.830 |
Why?
|
Diabetes Mellitus | 16 | 2023 | 5752 | 0.820 |
Why?
|
Myocardial Revascularization | 7 | 2021 | 841 | 0.820 |
Why?
|
Heart Injuries | 2 | 2021 | 210 | 0.820 |
Why?
|
Retrospective Studies | 67 | 2024 | 77410 | 0.810 |
Why?
|
Aortic Valve Insufficiency | 2 | 2016 | 579 | 0.810 |
Why?
|
Ammonia | 4 | 2023 | 239 | 0.810 |
Why?
|
Lifting | 1 | 2022 | 56 | 0.800 |
Why?
|
Heart Valve Prosthesis Implantation | 5 | 2021 | 1537 | 0.800 |
Why?
|
Adult | 115 | 2023 | 213889 | 0.790 |
Why?
|
Consensus | 14 | 2022 | 2954 | 0.790 |
Why?
|
Image Enhancement | 5 | 2016 | 2915 | 0.780 |
Why?
|
Health Expenditures | 12 | 2020 | 2348 | 0.770 |
Why?
|
Practice Guidelines as Topic | 13 | 2021 | 7270 | 0.770 |
Why?
|
Tachycardia, Ventricular | 9 | 2023 | 1272 | 0.760 |
Why?
|
Cardiac-Gated Imaging Techniques | 6 | 2014 | 143 | 0.760 |
Why?
|
United States | 96 | 2024 | 69859 | 0.750 |
Why?
|
Carotid Artery Diseases | 5 | 2020 | 875 | 0.740 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 253 | 0.730 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 35 | 0.730 |
Why?
|
Heart Rate | 10 | 2021 | 4091 | 0.730 |
Why?
|
Vasodilator Agents | 10 | 2021 | 974 | 0.720 |
Why?
|
Coronavirus Infections | 8 | 2020 | 3134 | 0.720 |
Why?
|
Magnetic Resonance Imaging | 30 | 2022 | 35409 | 0.720 |
Why?
|
Pneumonia, Viral | 8 | 2020 | 3241 | 0.710 |
Why?
|
Preventive Health Services | 3 | 2020 | 575 | 0.710 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2020 | 2074 | 0.710 |
Why?
|
Chi-Square Distribution | 17 | 2017 | 3503 | 0.700 |
Why?
|
Gadolinium | 6 | 2022 | 950 | 0.700 |
Why?
|
Diagnostic Techniques, Cardiovascular | 5 | 2021 | 153 | 0.700 |
Why?
|
Primary Prevention | 12 | 2021 | 1167 | 0.690 |
Why?
|
Death, Sudden, Cardiac | 9 | 2023 | 1542 | 0.690 |
Why?
|
Pandemics | 11 | 2021 | 8385 | 0.690 |
Why?
|
Risk Reduction Behavior | 6 | 2018 | 1125 | 0.680 |
Why?
|
Colchicine | 1 | 2020 | 244 | 0.660 |
Why?
|
Angina Pectoris | 5 | 2019 | 977 | 0.650 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2023 | 1265 | 0.650 |
Why?
|
Thoracic Surgical Procedures | 1 | 2022 | 342 | 0.640 |
Why?
|
Acute Coronary Syndrome | 10 | 2023 | 2337 | 0.630 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 11 | 2014 | 1184 | 0.610 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2020 | 136 | 0.610 |
Why?
|
Heart Neoplasms | 2 | 2019 | 374 | 0.600 |
Why?
|
Follow-Up Studies | 40 | 2023 | 39001 | 0.600 |
Why?
|
Recovery of Function | 3 | 2020 | 2922 | 0.600 |
Why?
|
Emergency Service, Hospital | 15 | 2023 | 7658 | 0.600 |
Why?
|
Reproducibility of Results | 32 | 2023 | 19894 | 0.600 |
Why?
|
Cardiovascular Agents | 4 | 2020 | 850 | 0.600 |
Why?
|
Ventricular Remodeling | 7 | 2022 | 1225 | 0.590 |
Why?
|
Aortography | 2 | 2016 | 437 | 0.590 |
Why?
|
Patient Advocacy | 1 | 2019 | 353 | 0.590 |
Why?
|
Arteritis | 1 | 2019 | 159 | 0.580 |
Why?
|
Nuclear Medicine | 7 | 2020 | 233 | 0.580 |
Why?
|
Kidney Diseases | 4 | 2020 | 2146 | 0.580 |
Why?
|
Time Factors | 46 | 2021 | 40038 | 0.570 |
Why?
|
Eligibility Determination | 2 | 2017 | 404 | 0.570 |
Why?
|
Heart Transplantation | 7 | 2021 | 3113 | 0.570 |
Why?
|
Radiology, Interventional | 1 | 2020 | 460 | 0.560 |
Why?
|
Health Care Costs | 11 | 2021 | 3207 | 0.560 |
Why?
|
Echocardiography, Stress | 2 | 2014 | 131 | 0.560 |
Why?
|
Psoriasis | 2 | 2021 | 901 | 0.550 |
Why?
|
Mucormycosis | 1 | 2017 | 97 | 0.550 |
Why?
|
Cardiology Service, Hospital | 2 | 2020 | 246 | 0.550 |
Why?
|
Appointments and Schedules | 1 | 2020 | 417 | 0.550 |
Why?
|
Electrophysiologic Techniques, Cardiac | 2 | 2020 | 493 | 0.540 |
Why?
|
Sinus of Valsalva | 1 | 2016 | 59 | 0.530 |
Why?
|
Prosthesis Fitting | 1 | 2015 | 74 | 0.530 |
Why?
|
Young Adult | 35 | 2022 | 56392 | 0.530 |
Why?
|
Triage | 4 | 2016 | 977 | 0.530 |
Why?
|
Sensitivity and Specificity | 29 | 2023 | 14714 | 0.520 |
Why?
|
Coronary Artery Bypass | 7 | 2021 | 2288 | 0.520 |
Why?
|
Aspergillosis | 1 | 2017 | 235 | 0.520 |
Why?
|
Image Interpretation, Computer-Assisted | 7 | 2019 | 3320 | 0.520 |
Why?
|
Arrhythmias, Cardiac | 10 | 2023 | 2267 | 0.510 |
Why?
|
Hemodynamics | 4 | 2019 | 4197 | 0.510 |
Why?
|
Thrombosis | 3 | 2018 | 2968 | 0.510 |
Why?
|
Prevalence | 24 | 2021 | 15211 | 0.500 |
Why?
|
Treatment Outcome | 35 | 2021 | 63042 | 0.500 |
Why?
|
Heart Valve Diseases | 3 | 2014 | 1073 | 0.500 |
Why?
|
Aortic Diseases | 3 | 2016 | 743 | 0.500 |
Why?
|
Syncope | 3 | 2018 | 429 | 0.490 |
Why?
|
Tricuspid Atresia | 1 | 2014 | 36 | 0.490 |
Why?
|
Ventricular Function | 1 | 2016 | 415 | 0.490 |
Why?
|
Biopsy | 9 | 2020 | 6750 | 0.490 |
Why?
|
Candidiasis | 1 | 2017 | 366 | 0.490 |
Why?
|
Cocaine-Related Disorders | 1 | 2018 | 460 | 0.490 |
Why?
|
Tricuspid Valve | 2 | 2017 | 403 | 0.480 |
Why?
|
Heart Murmurs | 1 | 2014 | 94 | 0.480 |
Why?
|
Lipids | 5 | 2019 | 3307 | 0.480 |
Why?
|
Natural Language Processing | 2 | 2023 | 1041 | 0.480 |
Why?
|
Fabry Disease | 1 | 2014 | 89 | 0.480 |
Why?
|
Societies, Medical | 14 | 2021 | 3740 | 0.470 |
Why?
|
Catheter Ablation | 8 | 2021 | 2758 | 0.470 |
Why?
|
Health Resources | 3 | 2017 | 912 | 0.470 |
Why?
|
Cause of Death | 12 | 2021 | 3580 | 0.470 |
Why?
|
Rubidium Radioisotopes | 4 | 2014 | 85 | 0.460 |
Why?
|
Quality Indicators, Health Care | 4 | 2020 | 1831 | 0.460 |
Why?
|
Abscess | 1 | 2017 | 607 | 0.460 |
Why?
|
Central Nervous System Diseases | 1 | 2018 | 518 | 0.450 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2016 | 262 | 0.450 |
Why?
|
Pulmonary Valve | 1 | 2017 | 437 | 0.440 |
Why?
|
Radiography, Interventional | 1 | 2020 | 1095 | 0.440 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2012 | 30 | 0.440 |
Why?
|
Adenosine | 4 | 2011 | 825 | 0.440 |
Why?
|
Cocaine | 1 | 2018 | 1007 | 0.440 |
Why?
|
Subtraction Technique | 2 | 2013 | 523 | 0.440 |
Why?
|
Incidence | 29 | 2020 | 20948 | 0.430 |
Why?
|
Embolism | 1 | 2016 | 407 | 0.430 |
Why?
|
Aneurysm, False | 2 | 2012 | 276 | 0.430 |
Why?
|
Proportional Hazards Models | 18 | 2023 | 12354 | 0.430 |
Why?
|
Microcirculation | 6 | 2023 | 1287 | 0.420 |
Why?
|
Prospective Studies | 46 | 2024 | 53250 | 0.410 |
Why?
|
Cardiotonic Agents | 2 | 2014 | 535 | 0.410 |
Why?
|
Heart Aneurysm | 1 | 2012 | 120 | 0.410 |
Why?
|
Aged, 80 and over | 51 | 2021 | 57744 | 0.410 |
Why?
|
Massachusetts | 8 | 2020 | 8660 | 0.400 |
Why?
|
Obesity | 16 | 2023 | 12744 | 0.400 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2019 | 2200 | 0.400 |
Why?
|
Emergency Medical Services | 2 | 2014 | 1917 | 0.400 |
Why?
|
Mass Screening | 3 | 2017 | 5251 | 0.400 |
Why?
|
Boston | 12 | 2019 | 9310 | 0.400 |
Why?
|
Acetanilides | 1 | 2013 | 168 | 0.400 |
Why?
|
Decision Making | 2 | 2019 | 3887 | 0.400 |
Why?
|
Information Dissemination | 1 | 2019 | 1099 | 0.390 |
Why?
|
Fasting | 2 | 2022 | 1590 | 0.390 |
Why?
|
Mitral Valve Insufficiency | 2 | 2018 | 1421 | 0.390 |
Why?
|
North America | 4 | 2022 | 1249 | 0.380 |
Why?
|
Cost Savings | 7 | 2020 | 925 | 0.380 |
Why?
|
Angiocardiography | 1 | 2010 | 162 | 0.380 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2016 | 573 | 0.370 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2023 | 858 | 0.370 |
Why?
|
Evidence-Based Medicine | 5 | 2020 | 3608 | 0.370 |
Why?
|
Systole | 5 | 2020 | 958 | 0.370 |
Why?
|
ROC Curve | 8 | 2016 | 3527 | 0.360 |
Why?
|
Artifacts | 3 | 2014 | 1904 | 0.360 |
Why?
|
Edema, Cardiac | 1 | 2009 | 18 | 0.360 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1789 | 0.360 |
Why?
|
Impotence, Vasculogenic | 2 | 2020 | 11 | 0.360 |
Why?
|
Multivariate Analysis | 18 | 2017 | 12243 | 0.360 |
Why?
|
Family Health | 2 | 2014 | 1280 | 0.350 |
Why?
|
Age Factors | 15 | 2021 | 18355 | 0.350 |
Why?
|
Artificial Intelligence | 5 | 2023 | 2210 | 0.350 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2012 | 488 | 0.350 |
Why?
|
Sex Factors | 12 | 2020 | 10394 | 0.350 |
Why?
|
Odds Ratio | 14 | 2018 | 9848 | 0.350 |
Why?
|
Coronary Aneurysm | 1 | 2012 | 237 | 0.350 |
Why?
|
Organometallic Compounds | 4 | 2019 | 665 | 0.350 |
Why?
|
Hospital Costs | 3 | 2019 | 985 | 0.340 |
Why?
|
Cohort Studies | 23 | 2022 | 40545 | 0.340 |
Why?
|
Education, Medical, Graduate | 3 | 2020 | 2291 | 0.340 |
Why?
|
Health Status Indicators | 1 | 2014 | 970 | 0.340 |
Why?
|
General Practitioners | 1 | 2010 | 103 | 0.340 |
Why?
|
Models, Cardiovascular | 4 | 2021 | 996 | 0.330 |
Why?
|
Smoking Cessation | 2 | 2020 | 2071 | 0.330 |
Why?
|
Disease Progression | 16 | 2022 | 13273 | 0.330 |
Why?
|
Echocardiography, Transesophageal | 6 | 2020 | 1133 | 0.330 |
Why?
|
Ambulatory Care | 3 | 2019 | 2707 | 0.330 |
Why?
|
Aorta | 2 | 2016 | 2062 | 0.330 |
Why?
|
Inflammation | 12 | 2023 | 10629 | 0.330 |
Why?
|
Mortality | 4 | 2021 | 2862 | 0.320 |
Why?
|
Research Report | 2 | 2021 | 355 | 0.320 |
Why?
|
Heart Defects, Congenital | 3 | 2019 | 4584 | 0.320 |
Why?
|
Age of Onset | 3 | 2021 | 3268 | 0.320 |
Why?
|
Survival Analysis | 9 | 2021 | 10251 | 0.320 |
Why?
|
Pulmonary Veins | 4 | 2014 | 761 | 0.310 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2009 | 124 | 0.310 |
Why?
|
Socioeconomic Factors | 8 | 2024 | 7784 | 0.310 |
Why?
|
Kidney Failure, Chronic | 2 | 2018 | 2534 | 0.310 |
Why?
|
Renal Circulation | 1 | 2008 | 334 | 0.310 |
Why?
|
Health Status | 5 | 2019 | 4031 | 0.310 |
Why?
|
Quality Improvement | 2 | 2020 | 3750 | 0.310 |
Why?
|
Algorithms | 10 | 2021 | 13869 | 0.310 |
Why?
|
Survival Rate | 12 | 2020 | 12786 | 0.300 |
Why?
|
Biomedical Research | 2 | 2020 | 3308 | 0.300 |
Why?
|
Gadolinium DTPA | 8 | 2019 | 836 | 0.300 |
Why?
|
Occupational Health | 4 | 2021 | 808 | 0.290 |
Why?
|
Renin-Angiotensin System | 2 | 2008 | 758 | 0.290 |
Why?
|
Perfusion | 5 | 2023 | 1359 | 0.290 |
Why?
|
Medically Uninsured | 4 | 2021 | 853 | 0.290 |
Why?
|
Preventive Medicine | 2 | 2019 | 263 | 0.290 |
Why?
|
Heart Valves | 2 | 2018 | 291 | 0.290 |
Why?
|
Angiography | 1 | 2012 | 1638 | 0.280 |
Why?
|
Guideline Adherence | 5 | 2020 | 2265 | 0.280 |
Why?
|
Aspirin | 5 | 2023 | 3283 | 0.280 |
Why?
|
Diffusion of Innovation | 3 | 2020 | 725 | 0.280 |
Why?
|
Atrial Fibrillation | 8 | 2018 | 5033 | 0.280 |
Why?
|
Shock, Cardiogenic | 2 | 2022 | 688 | 0.280 |
Why?
|
Meglumine | 3 | 2019 | 149 | 0.270 |
Why?
|
Hypertension | 8 | 2022 | 8480 | 0.270 |
Why?
|
Purines | 3 | 2015 | 590 | 0.270 |
Why?
|
Forecasting | 3 | 2020 | 2950 | 0.270 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2011 | 591 | 0.270 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3712 | 0.270 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 2005 | 33 | 0.270 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2021 | 3921 | 0.270 |
Why?
|
Kaplan-Meier Estimate | 10 | 2019 | 6539 | 0.260 |
Why?
|
Drug Costs | 3 | 2018 | 1105 | 0.260 |
Why?
|
Automation | 2 | 2023 | 584 | 0.260 |
Why?
|
Patient Selection | 9 | 2019 | 4210 | 0.260 |
Why?
|
Asymptomatic Diseases | 6 | 2019 | 552 | 0.260 |
Why?
|
Patient-Centered Care | 3 | 2021 | 1438 | 0.260 |
Why?
|
Electrophysiology | 1 | 2008 | 1297 | 0.260 |
Why?
|
Troponin T | 5 | 2023 | 754 | 0.250 |
Why?
|
Fibrosis | 7 | 2023 | 2030 | 0.250 |
Why?
|
Kidney | 4 | 2023 | 7185 | 0.250 |
Why?
|
C-Reactive Protein | 7 | 2023 | 3778 | 0.250 |
Why?
|
Policy Making | 2 | 2019 | 554 | 0.240 |
Why?
|
Immunotherapy | 1 | 2020 | 4437 | 0.240 |
Why?
|
Safety Management | 2 | 2020 | 782 | 0.240 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1859 | 0.240 |
Why?
|
Technetium Tc 99m Pyrophosphate | 2 | 2020 | 44 | 0.240 |
Why?
|
Blood Pressure | 8 | 2018 | 8551 | 0.230 |
Why?
|
Cost-Benefit Analysis | 7 | 2020 | 5388 | 0.230 |
Why?
|
Long QT Syndrome | 1 | 2008 | 453 | 0.230 |
Why?
|
Influenza Vaccines | 2 | 2021 | 738 | 0.230 |
Why?
|
Hospital Mortality | 6 | 2022 | 5316 | 0.230 |
Why?
|
Healthcare Disparities | 6 | 2022 | 3155 | 0.220 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 11729 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2023 | 9944 | 0.220 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2023 | 44 | 0.220 |
Why?
|
Linear Models | 9 | 2019 | 5952 | 0.220 |
Why?
|
Amyloidosis | 3 | 2020 | 795 | 0.220 |
Why?
|
Stroke | 7 | 2023 | 9975 | 0.220 |
Why?
|
Cadmium | 2 | 2022 | 212 | 0.220 |
Why?
|
Diagnosis, Differential | 8 | 2020 | 12954 | 0.220 |
Why?
|
Comorbidity | 7 | 2021 | 10380 | 0.220 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 37 | 0.210 |
Why?
|
Curriculum | 4 | 2020 | 3603 | 0.210 |
Why?
|
Life Style | 4 | 2020 | 3833 | 0.210 |
Why?
|
Income | 3 | 2021 | 1913 | 0.210 |
Why?
|
Piperazines | 1 | 2013 | 2487 | 0.210 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1619 | 0.210 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2023 | 3758 | 0.210 |
Why?
|
Magnetic Resonance Angiography | 3 | 2014 | 1444 | 0.210 |
Why?
|
Tomography, Spiral Computed | 2 | 2016 | 280 | 0.200 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2018 | 364 | 0.200 |
Why?
|
Myocardial Contraction | 2 | 2019 | 1579 | 0.200 |
Why?
|
Tomography Scanners, X-Ray Computed | 2 | 2020 | 169 | 0.200 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 680 | 0.200 |
Why?
|
Decision Support Techniques | 4 | 2017 | 1956 | 0.200 |
Why?
|
Awareness | 2 | 2019 | 639 | 0.200 |
Why?
|
Imaging, Three-Dimensional | 3 | 2015 | 4033 | 0.200 |
Why?
|
Health Surveys | 7 | 2021 | 4036 | 0.190 |
Why?
|
Clinical Trials as Topic | 4 | 2021 | 7908 | 0.190 |
Why?
|
Tellurium | 1 | 2020 | 23 | 0.190 |
Why?
|
Length of Stay | 6 | 2022 | 6311 | 0.190 |
Why?
|
Brazil | 4 | 2020 | 1264 | 0.190 |
Why?
|
Logistic Models | 11 | 2019 | 13404 | 0.190 |
Why?
|
Hypercholesterolemia | 3 | 2023 | 1151 | 0.190 |
Why?
|
Medicare | 3 | 2021 | 6565 | 0.190 |
Why?
|
Mummies | 1 | 2019 | 10 | 0.180 |
Why?
|
Observer Variation | 7 | 2019 | 2592 | 0.180 |
Why?
|
Heart Conduction System | 2 | 2021 | 1047 | 0.180 |
Why?
|
Referral and Consultation | 2 | 2010 | 3530 | 0.180 |
Why?
|
Microvessels | 2 | 2015 | 544 | 0.180 |
Why?
|
Diet | 5 | 2021 | 7930 | 0.180 |
Why?
|
Nutritional Sciences | 1 | 2021 | 137 | 0.180 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2020 | 43 | 0.180 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2021 | 235 | 0.180 |
Why?
|
Secondary Prevention | 2 | 2023 | 1529 | 0.180 |
Why?
|
Zinc | 2 | 2022 | 683 | 0.180 |
Why?
|
Fee Schedules | 1 | 2019 | 86 | 0.170 |
Why?
|
Clinical Competence | 4 | 2020 | 4687 | 0.170 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2021 | 370 | 0.170 |
Why?
|
Menu Planning | 1 | 2019 | 30 | 0.170 |
Why?
|
Health Services Misuse | 1 | 2021 | 243 | 0.170 |
Why?
|
Smoking | 11 | 2021 | 8984 | 0.170 |
Why?
|
Body Mass Index | 12 | 2018 | 12718 | 0.170 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 314 | 0.170 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2020 | 194 | 0.170 |
Why?
|
Pyrazoles | 3 | 2015 | 1970 | 0.170 |
Why?
|
Prospective Payment System | 1 | 2019 | 133 | 0.170 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2020 | 397 | 0.170 |
Why?
|
Receptors, Somatostatin | 1 | 2019 | 129 | 0.160 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 230 | 0.160 |
Why?
|
Insurance, Health | 2 | 2021 | 2492 | 0.160 |
Why?
|
Journal Impact Factor | 1 | 2020 | 155 | 0.160 |
Why?
|
Defibrillators, Implantable | 2 | 2018 | 1439 | 0.160 |
Why?
|
Heart Arrest | 2 | 2022 | 1470 | 0.160 |
Why?
|
Breast Implants | 1 | 2022 | 387 | 0.160 |
Why?
|
Penile Erection | 1 | 2018 | 89 | 0.160 |
Why?
|
Diet Therapy | 1 | 2019 | 154 | 0.160 |
Why?
|
Congresses as Topic | 2 | 2020 | 763 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13112 | 0.160 |
Why?
|
Prediabetic State | 1 | 2023 | 499 | 0.160 |
Why?
|
Feasibility Studies | 10 | 2023 | 5078 | 0.160 |
Why?
|
Biomedical Technology | 1 | 2020 | 220 | 0.160 |
Why?
|
Thoracic Neoplasms | 1 | 2020 | 268 | 0.160 |
Why?
|
Prosthesis Failure | 3 | 2022 | 1203 | 0.150 |
Why?
|
Phospholipids | 1 | 2021 | 784 | 0.150 |
Why?
|
Autopsy | 2 | 2018 | 1020 | 0.150 |
Why?
|
Cholesterol | 4 | 2020 | 2922 | 0.150 |
Why?
|
Exercise | 6 | 2021 | 5611 | 0.150 |
Why?
|
Funnel Chest | 1 | 2018 | 71 | 0.150 |
Why?
|
Hospitals | 3 | 2020 | 3953 | 0.150 |
Why?
|
Fatty Liver | 2 | 2014 | 728 | 0.150 |
Why?
|
Fatal Outcome | 3 | 2017 | 1851 | 0.150 |
Why?
|
Financing, Personal | 1 | 2020 | 308 | 0.150 |
Why?
|
Diet, Mediterranean | 2 | 2022 | 700 | 0.150 |
Why?
|
Heart Failure, Diastolic | 1 | 2018 | 69 | 0.150 |
Why?
|
Nonlinear Dynamics | 2 | 2017 | 501 | 0.140 |
Why?
|
Rhabdomyolysis | 1 | 2018 | 150 | 0.140 |
Why?
|
Radiographic Image Enhancement | 2 | 2013 | 885 | 0.140 |
Why?
|
Fistula | 1 | 2018 | 221 | 0.140 |
Why?
|
Models, Economic | 3 | 2017 | 712 | 0.140 |
Why?
|
Minority Groups | 1 | 2024 | 1222 | 0.140 |
Why?
|
Bibliometrics | 1 | 2020 | 338 | 0.140 |
Why?
|
Longitudinal Studies | 9 | 2020 | 13980 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 8939 | 0.140 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1240 | 0.140 |
Why?
|
Overweight | 3 | 2022 | 2371 | 0.130 |
Why?
|
Endocarditis, Bacterial | 1 | 2020 | 455 | 0.130 |
Why?
|
Cross-Sectional Studies | 14 | 2022 | 25032 | 0.130 |
Why?
|
Heart Function Tests | 1 | 2016 | 328 | 0.130 |
Why?
|
Edema | 1 | 2019 | 789 | 0.130 |
Why?
|
Specialization | 1 | 2020 | 775 | 0.130 |
Why?
|
Preoperative Period | 1 | 2017 | 550 | 0.130 |
Why?
|
Thoracic Injuries | 1 | 2018 | 272 | 0.130 |
Why?
|
Area Under Curve | 2 | 2016 | 1654 | 0.130 |
Why?
|
Radionuclide Imaging | 3 | 2018 | 2034 | 0.130 |
Why?
|
Health Services | 2 | 2020 | 758 | 0.130 |
Why?
|
Double-Blind Method | 6 | 2017 | 12020 | 0.130 |
Why?
|
Insulin Resistance | 3 | 2022 | 3863 | 0.130 |
Why?
|
Tissue Survival | 2 | 2020 | 118 | 0.130 |
Why?
|
Incidental Findings | 1 | 2020 | 689 | 0.130 |
Why?
|
Hospitalization | 8 | 2023 | 10259 | 0.120 |
Why?
|
Debridement | 1 | 2017 | 492 | 0.120 |
Why?
|
Radiography | 3 | 2014 | 7010 | 0.120 |
Why?
|
Cost of Illness | 3 | 2020 | 1859 | 0.120 |
Why?
|
Radiology Information Systems | 1 | 2019 | 523 | 0.120 |
Why?
|
Pulmonary Embolism | 2 | 2018 | 2375 | 0.120 |
Why?
|
Radiation Protection | 3 | 2015 | 419 | 0.120 |
Why?
|
Takayasu Arteritis | 1 | 2015 | 96 | 0.120 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 537 | 0.120 |
Why?
|
Necrosis | 3 | 2020 | 1642 | 0.120 |
Why?
|
Computer Simulation | 3 | 2017 | 6188 | 0.120 |
Why?
|
Reimbursement Mechanisms | 1 | 2019 | 670 | 0.110 |
Why?
|
Protestantism | 2 | 2023 | 10 | 0.110 |
Why?
|
Diastole | 2 | 2017 | 791 | 0.110 |
Why?
|
Propensity Score | 1 | 2020 | 1781 | 0.110 |
Why?
|
Cicatrix | 2 | 2023 | 763 | 0.110 |
Why?
|
Aging | 3 | 2019 | 8655 | 0.110 |
Why?
|
Respiratory Rate | 1 | 2014 | 162 | 0.110 |
Why?
|
Hot Temperature | 1 | 2019 | 1351 | 0.110 |
Why?
|
Cerebrovascular Disorders | 1 | 2020 | 1504 | 0.110 |
Why?
|
Equipment Failure Analysis | 1 | 2015 | 864 | 0.110 |
Why?
|
Cardiac Volume | 1 | 2013 | 210 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.110 |
Why?
|
Atrial Function, Left | 1 | 2014 | 173 | 0.110 |
Why?
|
Adolescent | 16 | 2022 | 85729 | 0.110 |
Why?
|
Rest | 2 | 2015 | 901 | 0.110 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2018 | 581 | 0.110 |
Why?
|
Influenza, Human | 2 | 2021 | 1480 | 0.110 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2013 | 117 | 0.110 |
Why?
|
Ischemic Attack, Transient | 1 | 2018 | 934 | 0.110 |
Why?
|
Electronic Health Records | 2 | 2021 | 4467 | 0.110 |
Why?
|
Disease-Free Survival | 5 | 2019 | 6895 | 0.110 |
Why?
|
Adenosine A2 Receptor Agonists | 1 | 2012 | 27 | 0.110 |
Why?
|
Antifungal Agents | 1 | 2017 | 729 | 0.110 |
Why?
|
Fluorobenzenes | 2 | 2011 | 183 | 0.110 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2018 | 851 | 0.100 |
Why?
|
Bioprosthesis | 1 | 2017 | 597 | 0.100 |
Why?
|
Tomography, Emission-Computed | 1 | 2015 | 1143 | 0.100 |
Why?
|
Statistics, Nonparametric | 2 | 2016 | 2883 | 0.100 |
Why?
|
Health Behavior | 2 | 2022 | 2634 | 0.100 |
Why?
|
Anticoagulants | 2 | 2018 | 4599 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1546 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2022 | 2050 | 0.100 |
Why?
|
Prosthesis Design | 2 | 2015 | 2103 | 0.100 |
Why?
|
Radiosurgery | 1 | 2021 | 1331 | 0.100 |
Why?
|
Pacemaker, Artificial | 1 | 2017 | 815 | 0.100 |
Why?
|
Patient Readmission | 2 | 2018 | 3117 | 0.100 |
Why?
|
Models, Anatomic | 1 | 2015 | 690 | 0.100 |
Why?
|
Mammaplasty | 1 | 2022 | 1204 | 0.100 |
Why?
|
Florida | 2 | 2023 | 435 | 0.100 |
Why?
|
Liver Diseases | 1 | 2020 | 1253 | 0.100 |
Why?
|
Device Removal | 1 | 2017 | 655 | 0.100 |
Why?
|
Chronic Disease | 4 | 2021 | 9139 | 0.100 |
Why?
|
Vasodilation | 2 | 2012 | 944 | 0.100 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2012 | 876 | 0.100 |
Why?
|
Quality of Life | 3 | 2022 | 12788 | 0.100 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1525 | 0.100 |
Why?
|
Patient Acceptance of Health Care | 2 | 2022 | 3020 | 0.100 |
Why?
|
Advisory Committees | 1 | 2015 | 775 | 0.090 |
Why?
|
Athletes | 1 | 2018 | 1093 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2515 | 0.090 |
Why?
|
Risk | 4 | 2020 | 9677 | 0.090 |
Why?
|
Breast Neoplasms | 3 | 2022 | 20827 | 0.090 |
Why?
|
Case-Control Studies | 5 | 2021 | 21733 | 0.090 |
Why?
|
Coronary Occlusion | 1 | 2013 | 304 | 0.090 |
Why?
|
Risk Management | 1 | 2014 | 571 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1497 | 0.090 |
Why?
|
Watchful Waiting | 1 | 2014 | 491 | 0.090 |
Why?
|
Probability | 2 | 2014 | 2505 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2019 | 2073 | 0.090 |
Why?
|
Sex Distribution | 4 | 2019 | 2298 | 0.090 |
Why?
|
Antihypertensive Agents | 2 | 2010 | 2047 | 0.090 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2010 | 93 | 0.090 |
Why?
|
Injections, Intra-Arterial | 1 | 2009 | 193 | 0.090 |
Why?
|
Lymphoproliferative Disorders | 1 | 2013 | 524 | 0.090 |
Why?
|
Anticholesteremic Agents | 1 | 2017 | 979 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2017 | 1360 | 0.090 |
Why?
|
Recurrence | 4 | 2014 | 8337 | 0.090 |
Why?
|
Critical Pathways | 1 | 2013 | 476 | 0.090 |
Why?
|
Health Care Surveys | 4 | 2018 | 2453 | 0.090 |
Why?
|
Intra-Abdominal Fat | 1 | 2014 | 591 | 0.090 |
Why?
|
Health Status Disparities | 2 | 2019 | 1796 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1516 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6487 | 0.090 |
Why?
|
Molecular Probe Techniques | 1 | 2010 | 119 | 0.090 |
Why?
|
Ultrasonography, Doppler | 1 | 2011 | 458 | 0.080 |
Why?
|
Perioperative Care | 1 | 2016 | 1002 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1429 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2015 | 1431 | 0.080 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2013 | 546 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2104 | 0.080 |
Why?
|
Educational Status | 3 | 2023 | 2540 | 0.080 |
Why?
|
Particulate Matter | 1 | 2020 | 2529 | 0.080 |
Why?
|
Social Class | 1 | 2017 | 1997 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3089 | 0.080 |
Why?
|
Pressoreceptors | 1 | 2008 | 100 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4251 | 0.080 |
Why?
|
Heart Septum | 1 | 2009 | 312 | 0.080 |
Why?
|
Disease Management | 2 | 2020 | 2459 | 0.080 |
Why?
|
Hip Fractures | 1 | 2016 | 955 | 0.080 |
Why?
|
Unnecessary Procedures | 1 | 2012 | 432 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1404 | 0.080 |
Why?
|
Quality of Health Care | 3 | 2018 | 4370 | 0.080 |
Why?
|
Mitral Valve Prolapse | 1 | 2010 | 231 | 0.080 |
Why?
|
Fontan Procedure | 1 | 2014 | 776 | 0.080 |
Why?
|
Education, Medical | 1 | 2020 | 1722 | 0.080 |
Why?
|
Heart Block | 1 | 2009 | 410 | 0.080 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1265 | 0.080 |
Why?
|
Workplace | 1 | 2014 | 836 | 0.080 |
Why?
|
Substance-Related Disorders | 2 | 2021 | 4254 | 0.080 |
Why?
|
Hospitals, General | 1 | 2012 | 749 | 0.080 |
Why?
|
Rupture, Spontaneous | 2 | 2020 | 354 | 0.080 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2017 | 1209 | 0.070 |
Why?
|
Neoplasms | 4 | 2022 | 21675 | 0.070 |
Why?
|
Cardiomegaly | 1 | 2010 | 621 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1240 | 0.070 |
Why?
|
Adiposity | 2 | 2014 | 1806 | 0.070 |
Why?
|
Blood Volume | 1 | 2008 | 565 | 0.070 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2016 | 1344 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2683 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3389 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2760 | 0.070 |
Why?
|
Hospital Charges | 2 | 2019 | 362 | 0.070 |
Why?
|
Air Pollution | 1 | 2020 | 2286 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3391 | 0.070 |
Why?
|
Air Pollutants | 1 | 2020 | 2816 | 0.070 |
Why?
|
Syndrome | 1 | 2012 | 3249 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2015 | 1783 | 0.070 |
Why?
|
Poverty | 1 | 2017 | 2660 | 0.070 |
Why?
|
Midwestern United States | 1 | 2005 | 70 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2013 | 1403 | 0.070 |
Why?
|
Sympathetic Nervous System | 1 | 2008 | 513 | 0.070 |
Why?
|
Arterial Occlusive Diseases | 1 | 2010 | 793 | 0.070 |
Why?
|
Sleep Apnea Syndromes | 1 | 2014 | 944 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2012 | 2369 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4152 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5319 | 0.070 |
Why?
|
Radiometry | 1 | 2011 | 800 | 0.070 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 452 | 0.070 |
Why?
|
Health Services Accessibility | 2 | 2020 | 5136 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2017 | 3070 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2019 | 3264 | 0.060 |
Why?
|
Research Design | 2 | 2020 | 5983 | 0.060 |
Why?
|
Body Surface Area | 1 | 2005 | 199 | 0.060 |
Why?
|
Health Policy | 1 | 2017 | 2662 | 0.060 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4777 | 0.060 |
Why?
|
Pneumonia | 1 | 2016 | 2133 | 0.060 |
Why?
|
Sulfonamides | 2 | 2011 | 1938 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1854 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1743 | 0.060 |
Why?
|
Heart-Assist Devices | 1 | 2014 | 1195 | 0.060 |
Why?
|
Arteries | 2 | 2023 | 1119 | 0.060 |
Why?
|
Population Surveillance | 1 | 2014 | 2614 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3229 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3839 | 0.060 |
Why?
|
Body Weight | 2 | 2013 | 4670 | 0.060 |
Why?
|
Software | 2 | 2015 | 4440 | 0.060 |
Why?
|
Shock | 1 | 2005 | 318 | 0.050 |
Why?
|
Communication | 1 | 2017 | 3748 | 0.050 |
Why?
|
Dementia | 1 | 2016 | 2518 | 0.050 |
Why?
|
Nutrition Surveys | 2 | 2020 | 1660 | 0.050 |
Why?
|
Pyrimidines | 2 | 2011 | 2945 | 0.050 |
Why?
|
Blood Glucose | 4 | 2018 | 6259 | 0.050 |
Why?
|
Child, Preschool | 2 | 2022 | 40964 | 0.050 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2022 | 177 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3047 | 0.050 |
Why?
|
Iopamidol | 2 | 2014 | 191 | 0.050 |
Why?
|
Databases, Factual | 3 | 2019 | 7729 | 0.050 |
Why?
|
Age Distribution | 2 | 2019 | 2899 | 0.050 |
Why?
|
Health Promotion | 1 | 2014 | 2205 | 0.050 |
Why?
|
Internet | 1 | 2014 | 3058 | 0.050 |
Why?
|
Food Analysis | 1 | 2021 | 104 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2014 | 15281 | 0.050 |
Why?
|
Leadership | 2 | 2020 | 1357 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2013 | 1813 | 0.050 |
Why?
|
Diphosphates | 1 | 2020 | 88 | 0.050 |
Why?
|
Pericarditis | 1 | 2022 | 128 | 0.050 |
Why?
|
Denmark | 1 | 2023 | 738 | 0.050 |
Why?
|
Greenland | 1 | 2019 | 5 | 0.050 |
Why?
|
Radiation Injuries | 2 | 2022 | 1180 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10940 | 0.050 |
Why?
|
Cost Allocation | 1 | 2019 | 51 | 0.050 |
Why?
|
Maryland | 1 | 2020 | 276 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2278 | 0.050 |
Why?
|
Spironolactone | 1 | 2023 | 382 | 0.040 |
Why?
|
Food Service, Hospital | 1 | 2019 | 15 | 0.040 |
Why?
|
History, 16th Century | 1 | 2019 | 72 | 0.040 |
Why?
|
Ultrasonography | 2 | 2013 | 5986 | 0.040 |
Why?
|
Acute Disease | 3 | 2015 | 7150 | 0.040 |
Why?
|
Animals | 5 | 2019 | 168660 | 0.040 |
Why?
|
Search Engine | 1 | 2020 | 144 | 0.040 |
Why?
|
Breast Implantation | 1 | 2022 | 218 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2022 | 525 | 0.040 |
Why?
|
Prealbumin | 1 | 2020 | 207 | 0.040 |
Why?
|
Mediastinum | 1 | 2020 | 267 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 418 | 0.040 |
Why?
|
Tomography | 1 | 2020 | 389 | 0.040 |
Why?
|
Elastic Modulus | 1 | 2019 | 214 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9582 | 0.040 |
Why?
|
Carotid Artery, Common | 1 | 2019 | 183 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2020 | 336 | 0.040 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 213 | 0.040 |
Why?
|
Diet, Vegetarian | 1 | 2019 | 174 | 0.040 |
Why?
|
Drug Prescriptions | 2 | 2018 | 1636 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 923 | 0.040 |
Why?
|
Glomerular Filtration Rate | 2 | 2017 | 2167 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2020 | 593 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2009 | 3280 | 0.040 |
Why?
|
Hypercalcemia | 1 | 2020 | 409 | 0.040 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2020 | 585 | 0.040 |
Why?
|
Reference Values | 2 | 2016 | 4974 | 0.040 |
Why?
|
Organizational Policy | 1 | 2019 | 428 | 0.040 |
Why?
|
Regression Analysis | 2 | 2019 | 6457 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2020 | 866 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4839 | 0.040 |
Why?
|
Carotid Artery, Internal | 1 | 2019 | 445 | 0.040 |
Why?
|
Electric Impedance | 1 | 2020 | 729 | 0.040 |
Why?
|
Economics, Hospital | 1 | 2018 | 213 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1768 | 0.030 |
Why?
|
Endosonography | 1 | 2020 | 610 | 0.030 |
Why?
|
Bayes Theorem | 2 | 2017 | 2307 | 0.030 |
Why?
|
Emergency Treatment | 1 | 2019 | 517 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1532 | 0.030 |
Why?
|
Nutrition Policy | 1 | 2019 | 488 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 29777 | 0.030 |
Why?
|
Expert Testimony | 1 | 2017 | 355 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2022 | 1256 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1781 | 0.030 |
Why?
|
Self Concept | 1 | 2020 | 1024 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1918 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2020 | 861 | 0.030 |
Why?
|
Eye Diseases | 1 | 2020 | 668 | 0.030 |
Why?
|
Software Validation | 1 | 2014 | 59 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2014 | 101 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2020 | 2879 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8316 | 0.030 |
Why?
|
Radioisotopes | 1 | 2015 | 500 | 0.030 |
Why?
|
PubMed | 1 | 2014 | 121 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 674 | 0.030 |
Why?
|
Whole Body Imaging | 1 | 2015 | 282 | 0.030 |
Why?
|
Republic of Korea | 1 | 2015 | 538 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2018 | 866 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2012 | 6356 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 964 | 0.030 |
Why?
|
Hemorrhage | 2 | 2015 | 3458 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2013 | 229 | 0.030 |
Why?
|
Tennessee | 1 | 2012 | 117 | 0.030 |
Why?
|
Models, Educational | 1 | 2015 | 377 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2419 | 0.030 |
Why?
|
Tobacco Smoke Pollution | 1 | 2018 | 816 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2017 | 768 | 0.030 |
Why?
|
Quality Control | 1 | 2015 | 841 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1254 | 0.030 |
Why?
|
Lysosomal Storage Diseases | 1 | 2012 | 79 | 0.030 |
Why?
|
Drugs, Generic | 1 | 2017 | 421 | 0.030 |
Why?
|
Calcification, Physiologic | 1 | 2012 | 169 | 0.030 |
Why?
|
Extracellular Space | 1 | 2013 | 595 | 0.030 |
Why?
|
Ohio | 1 | 2012 | 337 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2029 | 0.030 |
Why?
|
Sample Size | 1 | 2015 | 841 | 0.020 |
Why?
|
Ischemia | 1 | 2020 | 1907 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2241 | 0.020 |
Why?
|
Documentation | 1 | 2017 | 871 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3336 | 0.020 |
Why?
|
Tunica Media | 1 | 2011 | 112 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 1683 | 0.020 |
Why?
|
Tachycardia | 2 | 1983 | 619 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 2010 | 124 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 975 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2013 | 935 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1534 | 0.020 |
Why?
|
Pericardium | 1 | 2014 | 667 | 0.020 |
Why?
|
Telemetry | 1 | 2010 | 208 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2971 | 0.020 |
Why?
|
Tunica Intima | 1 | 2011 | 463 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2014 | 1684 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2020 | 3476 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1275 | 0.020 |
Why?
|
Educational Measurement | 1 | 2015 | 1210 | 0.020 |
Why?
|
California | 1 | 2012 | 1402 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 2877 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1423 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1572 | 0.020 |
Why?
|
Teaching | 1 | 2015 | 1173 | 0.020 |
Why?
|
Waist Circumference | 1 | 2011 | 917 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1813 | 0.020 |
Why?
|
Death | 1 | 2011 | 678 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2011 | 949 | 0.020 |
Why?
|
Ventricular Function, Right | 1 | 2010 | 589 | 0.020 |
Why?
|
Vitamin D | 1 | 2020 | 3222 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1888 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2020 | 4232 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2453 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1188 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 3965 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2014 | 2159 | 0.010 |
Why?
|
Endomyocardial Fibrosis | 1 | 1983 | 41 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 1983 | 64 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2016 | 5096 | 0.010 |
Why?
|
Motor Activity | 1 | 2013 | 2714 | 0.010 |
Why?
|
Mental Health | 1 | 2017 | 3012 | 0.010 |
Why?
|
Fever | 1 | 2010 | 1616 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2010 | 1874 | 0.010 |
Why?
|
Dyspnea | 1 | 2010 | 1303 | 0.010 |
Why?
|
Ventricular Fibrillation | 1 | 1983 | 538 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 1983 | 844 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16361 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 21824 | 0.010 |
Why?
|
Internship and Residency | 1 | 2015 | 5787 | 0.010 |
Why?
|
Child | 1 | 2019 | 77637 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17439 | 0.010 |
Why?
|
Mice | 1 | 2013 | 81154 | 0.000 |
Why?
|
Sick Sinus Syndrome | 1 | 1983 | 44 | 0.000 |
Why?
|
Azathioprine | 1 | 1984 | 354 | 0.000 |
Why?
|
Electrodes | 1 | 1983 | 616 | 0.000 |
Why?
|
Prednisone | 1 | 1984 | 1574 | 0.000 |
Why?
|
Electric Stimulation | 1 | 1983 | 1760 | 0.000 |
Why?
|
Preoperative Care | 1 | 1983 | 2251 | 0.000 |
Why?
|